PL2214638T3 - Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny - Google Patents

Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny

Info

Publication number
PL2214638T3
PL2214638T3 PL08845987T PL08845987T PL2214638T3 PL 2214638 T3 PL2214638 T3 PL 2214638T3 PL 08845987 T PL08845987 T PL 08845987T PL 08845987 T PL08845987 T PL 08845987T PL 2214638 T3 PL2214638 T3 PL 2214638T3
Authority
PL
Poland
Prior art keywords
composition
fatty acids
polyunsaturated fatty
activated charcoal
charcoal
Prior art date
Application number
PL08845987T
Other languages
English (en)
Inventor
Catherine Kabaradjian
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of PL2214638T3 publication Critical patent/PL2214638T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08845987T 2007-10-30 2008-10-21 Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny PL2214638T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07291306 2007-10-30
PCT/EP2008/008882 WO2009056247A1 (en) 2007-10-30 2008-10-21 Composition comprising polyunsaturated fatty acids and activated charcoal
EP08845987A EP2214638B1 (en) 2007-10-30 2008-10-21 Composition comprising polyunsaturated fatty acids and activated charcoal

Publications (1)

Publication Number Publication Date
PL2214638T3 true PL2214638T3 (pl) 2012-06-29

Family

ID=40344798

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08845987T PL2214638T3 (pl) 2007-10-30 2008-10-21 Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny

Country Status (15)

Country Link
US (1) US20100260893A1 (pl)
EP (1) EP2214638B1 (pl)
AR (1) AR070759A1 (pl)
AT (1) ATE541560T1 (pl)
AU (1) AU2008317920B2 (pl)
BR (1) BRPI0818568A2 (pl)
CA (1) CA2703816C (pl)
ES (1) ES2379034T3 (pl)
MX (1) MX2010003703A (pl)
PE (1) PE20091076A1 (pl)
PL (1) PL2214638T3 (pl)
RU (1) RU2485940C2 (pl)
TW (1) TW200942229A (pl)
UY (1) UY31410A1 (pl)
WO (1) WO2009056247A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US20130108745A1 (en) * 2010-07-01 2013-05-02 Delante Health As Coated effervescent tablet
WO2013070856A1 (en) * 2011-11-09 2013-05-16 Denovo Inc. Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract
RU2524358C2 (ru) * 2012-07-24 2014-07-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
EP2994165A4 (en) * 2013-05-10 2017-01-04 Nitromega Corp. Nutritional or dietary supplements containing fatty acids and nitrite
EA025006B1 (ru) * 2013-08-22 2016-11-30 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
CN105935145B (zh) * 2015-12-18 2019-09-20 重庆两江药物研发中心有限公司 一种鱼油植物甾醇复合片剂及其制备方法
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法
EA201991467A1 (ru) * 2016-12-15 2019-11-29 Состав смеси, содержащий силикат и микробные и/или растительные клетки и полиненасыщенную жирную кислоту, имеющую по меньшей мере 20 атомов углерода (lc-pufa)
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702031A1 (de) 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0892587A (ja) 1994-09-22 1996-04-09 Baiotsukusu:Kk 魚臭のマスキング法
JP3534881B2 (ja) 1995-02-23 2004-06-07 太陽化学株式会社 乳化組成物
US6630192B2 (en) 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
RU2199317C2 (ru) * 1997-02-21 2003-02-27 Абботт Лаборэтриз Способ снижения заболеваемости некротическим энтероколитом у детей (варианты)
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
ES2246798T3 (es) 2000-05-18 2006-03-01 Q-Mega Healthcare A/S Complemento dietetico comprendiendo vitaminas, minerales y acidos grasos poliinsaturados.
JP2002204656A (ja) 2001-01-10 2002-07-23 Yakult Honsha Co Ltd 発酵乳飲食品及びその製造方法
DE20105126U1 (de) * 2001-03-23 2002-01-31 Bartz, Volker, 35440 Linden Fischöl zur oralen Einnahme
MXPA03011966A (es) * 2001-06-25 2004-03-26 Pharmacia Corp Metodo y dispositivo para producir tabletas revestidas por compresion.
EP1332759B1 (en) * 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
CN100384548C (zh) * 2002-08-14 2008-04-30 索莱有限责任公司 具有高液体负载的固体易流动粉末
CN1674786A (zh) 2002-08-14 2005-09-28 纳幕尔杜邦公司 经涂布的含多不饱和脂肪酸的颗粒以及经涂布的含液体药物的颗粒
CA2538886A1 (en) 2003-09-26 2005-04-07 Nestec S.A. Nutritional composition with unsaturated fatty acids and trace elements
DK1566173T3 (da) * 2004-02-20 2006-12-27 Mattern Udo Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
DE112006002050T5 (de) * 2005-08-03 2008-06-19 Sasol Technology (Proprietary) Ltd. Transport und Aufbau von sehr großen Behältern
GB0516069D0 (en) * 2005-08-04 2005-09-14 Imp College Innovations Ltd Pharmaceutical and use thereof

Also Published As

Publication number Publication date
AU2008317920A1 (en) 2009-05-07
CA2703816A1 (en) 2009-05-07
EP2214638B1 (en) 2012-01-18
US20100260893A1 (en) 2010-10-14
AR070759A1 (es) 2010-05-05
CA2703816C (en) 2016-07-19
UY31410A1 (es) 2009-05-29
PE20091076A1 (es) 2009-07-25
ES2379034T3 (es) 2012-04-20
RU2485940C2 (ru) 2013-06-27
TW200942229A (en) 2009-10-16
RU2010121714A (ru) 2011-12-10
BRPI0818568A2 (pt) 2015-04-22
MX2010003703A (es) 2010-07-30
WO2009056247A1 (en) 2009-05-07
ATE541560T1 (de) 2012-02-15
AU2008317920B2 (en) 2014-03-13
EP2214638A1 (en) 2010-08-11

Similar Documents

Publication Publication Date Title
PL2214638T3 (pl) Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny
EP2136844A4 (en) COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
GB2444896B (en) Compositions comprising polyunsaturated fatty acids
EP2197289A4 (en) SOLID FAT COMPOSITIONS CONTAINING MULTIPLE UNSATURATED FATTY ACIDS AND THEIR USES AND MANUFACTURING
EP2041047A4 (en) Fatty acid mixtures and their use
EP2121576A4 (en) MULTIPLE UNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES AND APPLICATIONS THEREOF
EP2324119A4 (en) DELTA5 MUTANT DESATURASES AND THEIR USE IN PRODUCTION OF POLYUNSATURATED FATTY ACIDS
ZA201003030B (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
EP2120920A4 (en) OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
EP2358882A4 (en) ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDS
ZA201008170B (en) Polypeptides and methods for producing triacyglycerols comprising modified fatty acids
EP2046957A4 (en) DATURURASES OF FATTY ACIDS AND USES THEREOF
HK1132433A1 (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
IL194078A0 (en) Plant seed oils containing polyunsaturated fatty acids
SI2408426T1 (sl) Oftalmični sestavki na osnovi polinenasičenih omega-3 in omega-6 maščobnih kislin
EP2061335A4 (en) GLYCERIDIC OIL COMPOSITION DERIVED FROM FISH OIL AND PREPARATION METHOD THEREOF
HUE050646T2 (hu) Eljárás többszörösen telített zsírsav és többszörösen telítetlen zsírsavat tartalmazó lipid elõállítására
EP2173184A4 (en) OMEGA TYPE ENRICHED FATTY ACID COMPOSITION
EP2234994A4 (en) MIXTURES OF FATTY ACIDS AND ALKYL ESTERS AND USES THEREOF
GB2464886B (en) Preparation of fatty acids in solid form
ZA200905273B (en) Compositions and methods of use of phorbol esters
EP2114397A4 (en) NOVEL CONJUGATES OF POLY-UNSATURATED FATTY ACIDS WITH AMINES AND THERAPEUTIC USES THEREOF
ZA200805714B (en) Antioxidant compositions useful in biodiesel and other fatty acid and acid ester compositions
PL2390339T3 (pl) Delta-8 desaturazy i ich zastosowanie w wytwarzaniu polinienasyconych kwasów tłuszczowych
EP2094242A4 (en) IN A MATRIX EMBEDDED COMPOSITIONS WITH ORGANIC ACIDS AND FATTY ACIDS